Clinical Trial

Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated October 31, 2023 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is an observational study of patients diagnosed with pancreatic cancer by pathology, with a control group of patients with pathology suggestive of benign pancreatic lesions and normal subjects, and the diagnostic ability of exosomes to identify patients with pancreatic cancer was assessed through the detection of exosomes in the peripheral blood.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-09
Trial Details
NCT Number NCT06108531
Lead Sponsor Shanghai Jiao Tong University School of Medicine
Conditions Pancreatic
Enrollment 400 participants
Start Date 2023-11-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2023-10-31